Aurobindo Pharma reports Q4 net profit at Rs 404 crore

Aurobindo Pharma today reported a consolidated net profit of Rs 403.80 crore for the fourth quarter ended March 31, 2015.
The company had posted a net profit of Rs 501.81 crore during the corresponding period of previous fiscal.
Net sales of the company stood at Rs 3,142.46 crore for the fourth quarter, while the same stood at Rs 2,305.88 crore during the corresponding period of previous year, Aurobindo Pharma said in a filing to the BSE.
For the year ended March 2015, the company posted a net profit of Rs 1,575.77 crore, while the same was Rs 1,172.85 crore in the previous year.

Net sales of the company for the year ended March 2015 stood at Rs 12,043.23 crore, against Rs 8,038.48 crore in the previous year.
The company said results of the quarter and the year ended March 31, 2015 are not comparable to the previous financial year due to the company acquiring assets in 2014.

Meanwhile, the company's Board, which met today, considered and approved third interim dividend of 100 per cent, or Re 1 per equity share of Re 1 each, for the year 2014-15.
The Board did not recommend any further dividend for the year 2014-15.
Aurobindo Pharma shares today ended 2.57 per cent down at Rs 1,304.15 apiece on the BSE.